Patent ID: 9555113
Date: 2017-01-31
CPC Classifications: A61K,A61P

Claim:
1. A composition comprising: oxycodone; sucrose acetate isobutyrate (SAIB), wherein the SAIB is present in the composition in an amount from about 35% by weight to about 45% by weight relative to the total weight of the composition; triacetin, wherein the triacetin is present in the composition in an amount from about 31% by weight to about 45% by weight relative to the total weight of the composition; isopropyl myristate (IPM), wherein the IPM is present in the composition in an amount from about 2% by weight to about 10% by weight relative to the total weight of the composition; cellulose acetate butyrate (CAB), wherein the CAB is present in the composition at about 2% to about 10% by weight relative to the total weight of the composition; hydroxyethyl cellulose (HEC), wherein the HEC is present in the composition in an amount from about 2% by weight to about 7% by weight relative to the total weight of the composition; and silicon dioxide, wherein the silicon dioxide is present in the composition in an amount from 2.4% by weight to about 4.0% by weight relative to the total weight of the composition, wherein the composition is contained within a capsule.